Kyle Jenne
About Kyle Jenne
Kyle Jenne is the Executive Vice President and Chief Global Product Strategy Officer at Ionis, with over 25 years of experience in the biopharmaceutical industry, specializing in the commercialization of medicines across various therapeutic areas.
Kyle Jenne Executive Vice President and Chief Global Product Strategy Officer
Kyle Jenne holds the title of Executive Vice President and Chief Global Product Strategy Officer at Ionis. In this role, he oversees all aspects of commercialization, including marketing, sales, commercial operations, market access, and patient services. His responsibilities also extend to managing Ionis' portfolio planning, market insights, and medical affairs functions.
Kyle Jenne Education and Expertise
Kyle Jenne earned a Bachelor of Science degree in Marketing from Arizona State University. He has over 25 years of biopharmaceutical experience, particularly in launching and commercializing innovative medicines both in the U.S. and globally. His expertise spans rare, specialty, and common diseases and includes therapeutic areas such as cardiovascular, neurology, and allergy.
Kyle Jenne Background in Biopharmaceutical Industry
Kyle Jenne has an extensive background in the biopharmaceutical industry. Before his tenure at Ionis, he spent five years in senior commercial leadership roles at Ionis and Akcea, a company that was fully acquired by Ionis in 2020. Additionally, he previously held various commercial roles at companies like Schering Plough, King Pharmaceuticals, Acorda Therapeutics, and Praecis Pharmaceuticals.